Patents by Inventor Diana Julia Leeming

Diana Julia Leeming has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9459260
    Abstract: An assay for citrullinated fragments of SOCS-2, Alpha 1 anti tyrpsin, versican, biglycan, laminin, or other protein having a terminal antibody binding site comprising citrulline in a blood derived sample shows diagnostic relevance in relation to rheumatoid arthritis or fibrotic disease.
    Type: Grant
    Filed: May 23, 2012
    Date of Patent: October 4, 2016
    Assignee: Nordic Bioscience A/S
    Inventors: Diana Julia Leeming, Morten Karsdal, Efstathios Vassiliadis
  • Publication number: 20150125964
    Abstract: An assay for citrullinated fragments of SOCS-2, Alpha 1 anti tyrpsin, versican, biglycan, laminin, or other protein having a terminal antibody binding site comprising citrulline in a blood derived sample shows diagnostic relevance in relation to rheumatoid arthritis or fibrotic disease.
    Type: Application
    Filed: May 23, 2012
    Publication date: May 7, 2015
    Applicant: Nordic Biosciences A/S
    Inventors: Diana Julia Leeming, Morten Karsdal, Efstathios Vassiliadis
  • Publication number: 20140295469
    Abstract: A bioassay for the quantification of peptide fragments comprising a neo-epitope formed by cleavage of a titin protein by a proteinase comprises contacting a sample with an antibody specifically binding said neo-epitope and determining the level of binding.
    Type: Application
    Filed: July 6, 2012
    Publication date: October 2, 2014
    Inventors: Diana Julia Leeming, Morten Karsdal, Efstathios Vassiliadis